Abstract

Compounding for the Dental Patient: A Focus on Ulcers of the Mouth

Author(s): Bassani August S, Keim David

Issue: Nov/Dec 2004 - Endotoxin

Page(s): 436-440

Download in electronic PDF format for $75
  • Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 1
  • Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 2
  • Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 3
  • Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 4
  • Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 5

Abstract

Many unique therapeutic challenges in dentistry call beyond the realm of commercially available solutions. As a partner-in-care, the compounding pharmacist has the potential to make significant contributions to the care of dental patients. One area in which this is particularly true is the common oral ulcers, especially recurrent aphthous stomatitis (canker sores), herpes simplex ulcers (cold sores), and lichen planus. The most common symptom of these conditions is pain. Treatment strategies include decreasing exposure to predisposing factors or infectious agents (by educating patients) and managing symptoms. Topical therapies are usually adequate in all but the most severe or widespread ulcers. Mucosal adhesion of topical therapies is a problem that can be overcome in some patients by use of a “mucosal bandage,” which is applied as a dry powder and turns to an occlusive gel on hydration. The gel protects the ulcer while it heals and may include anti-infective, anti-inflammatory, wound healing, and analgesic components. Other dosage forms, such as traditional gels or rinses, containing similar components may be more appropriate for some patients. In the initial, acute stage of herpes simplex infection, analgesics may be needed to treat fever and pain. Recurrent herpes ulcers of the lip (herpes labialis), however, usually can be treated with customized lip balm or ointment containing sunscreen as well as anti-infective, anti-inflammatory, and analgesic agents. Although lichen planus may cause no symptoms, the ulcerative form often causes severe pain. Systemic steroids are required in some patients to reduce pain and inflammation, but topical preparations have a tole in symptom relief (eg, anti-inflammatory agents) and modulation of the immune system (eg, mast-cell stabilizers, inhibitors of tumor necrosis factor alpha).

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2004
Pg. 436-440
Jul/Aug 2004
Pg. 265-267
Author(s): Wynn Tom
Mar/Apr 2023
Pg. 144
Author(s): Allen Loyd V Jr
May/Jun 2009
Pg. 214-217
Jan/Feb 2011
Pg. 13-18
May/Jun 2020
Pg. 182-186
Author(s): Riepl Mike
Mar/Apr 2022
Pg. 94-98
Author(s): Riepl Mike
Nov/Dec 2012
Pg. 462-469
Author(s): Zur Eyal
Sep/Oct 2022
Pg. 364-368
Author(s): Riepl Mike
Jan/Feb 2017
Pg. 22-27
May/Jun 2003
Pg. 176-178
Author(s): Israel Alan
Mar/Apr 2016
Pg. 146
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 278-281
Author(s): Riepl Mike
Sep/Oct 2010
Pg. 395-399
Sep/Oct 2011
Pg. 376-380
Author(s): McElhiney Linda F
May/Jun 2019
Pg. 250-257
Mar/Apr 2024
Pg. 94-98
Author(s): McElhiney Linda F
Sep/Oct 2009
Pg. 372-381
May/Jun 2003
Pg. 171
Author(s): Meece Jerry
Jan/Feb 1999
Pg. 49
Author(s): Allen Loyd V Jr